🔎 Trials Near Me

Dachaigh › Aillse a' bhroilleach › Oklahoma

Sgrùdaidhean clionaigeach Aillse a' bhroilleach ann an Oklahoma

Tha 20 sgrùdaidhean airson Aillse a' bhroilleach a’ lorg phàirtichean aig làraichean ann an Oklahoma.

Bailtean ann an Oklahoma

Teacsa sgrùdaidh oifigeil (Beurla)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 45 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06995898

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Oklahoma, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Oklahoma City, Oklahoma City
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

  • Oklahoma Proton Center, Oklahoma City
A’ fastadhÌre 2
Aoisean 50 agus nas sine · Banairean · Air ùrachadh 29 Sult 2026 · NCT01766297

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05867251

Biopsy-site-marker in Breast Cancer

  • OU Health Stephenson Cancer Center, Oklahoma City
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 22 Sult 2026 · NCT07833566

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Oklahoma Cancer Specialists and Research Institute (OCSRI) - Tulsa Cancer Center, Tulsa
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06492616

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • OU Health Stephenson Cancer Center, Oklahoma City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06253871

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Cancer Centers of Southwest Oklahoma Research, Lawton
  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
A’ fastadhÌre 3
Aoisean 18 gu 60 · Banairean · Air ùrachadh 2 Sult 2026 · NCT05879926

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06500481

E-Mindfulness Approaches for Living After Breast Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
A’ fastadhÌre 3
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06748222

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • University of Oklahoma - Health Sciences Center, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Stephenson Cancer Center Oklahoma University Health, Oklahoma City
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT05377996

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
A’ fastadhÌre 3
Aoisean 50 gu 70 · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT04852887

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Mercy Hospital Oklahoma City, Oklahoma City
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Màrt 2026 · NCT06418204

Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy

  • Stephenson Cancer Center, Oklahoma City
  • Stephenson Cancer Center- Tulsa, Tulsa
A’ fastadhÌre 1 tràth
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 26 Faoi 2026 · NCT05921253

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

  • OU Health Stephenson Cancer Center, Oklahoma City
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Dùbh 2025 · NCT07014618

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Tulsa
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

  • Exelixis Clinical Site #13, Oklahoma City
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Sult 2025 · NCT05932862

BostonGene and Exigent Genomic INsight Study

  • Oklahoma Cancer Specialists and Research Institute, Tulsa
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Gearr 2025 · NCT06272864

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.